🔴 Intravenous Infusions is trading 5% down today; no specific catalyst identified

Intravenous Infusions is trading 5% down at GHS 0.57 after another weak session on September 9, 2026; no company-specific catalyst has been identified.

• No company-specific announcement, earnings release, filing, or major transaction has been identified to explain the decline.
• The broader market backdrop remains cautious amid geopolitical tensions, higher crude prices, and inflation concerns, but available index moves do not establish a direct cause.